InvestorsHub Logo
icon url

Ecomike

01/20/20 8:43 PM

#3559 RE: Aquahoya #3556

$MILV has many attractions, like no debt and no new shares and locked low float.

But I like the 1-2 punch of an $MILV Biotech birth tackling the Brain injury and Brain diseases with a new generation of Liposomes and an immediate drink line that detoxifies alcohol and toxic drugs in the liver, that needs no FDA approval

A 4 time drink line racehorse master leading the company that had a drink line sold through Coke years ago, and sold another drink line about 13 years ago.....